Posts by Ming Li, MD
-
Local NAMPT Inhibition Enhances Checkpoint Immunotherapy for Glioblastoma
In a mouse model of glioblastoma, sequential therapy with a nicotinamide phosphoribosyltransferase inhibitor, delivered locally via polymer microparticles, and an immune checkpoint inhibitor improved survival over either agent used as monotherapy.
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
